Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Patients With HBV Twice as Likely to Develop Non-Hodgkin's Lymphoma NEW YORK -- August 3, 2010 -- A study published online first and appearing in an upcoming edition of The Lancet Oncology shows that patients with hepatitis B virus (HBV) are around twice as likely to develop a common form of non-Hodgkin lymphoma (NHL). Several studies have already established a causal link between hepatitis C virus (HCV) and increased risk of NHL, but studies on hepatitis B and NHL have so far been small. The link to NHL for both HBV and HCV is thought to involve chronic immune stimulation in the setting of sustained liver infection. Sustained immune activation may lead lymphocytes to develop DNA mutations that can promote their proliferation and progression to NHL. HBV infection was endemic in South Korea until 1995, when universal HBV vaccination of neonates was implemented. Before the introduction of vaccination, about 7% of South Korean adults had detectable plasma concentrations of hepatitis B surface antigen (HBsAg), which is consistent with chronic HBV infection. HBV infection remains common in South Korean adults, despite the availability of neonatal vaccination, because of infections acquired in childhood during previous years. In this study, Eric Engels, MD, National Cancer Institute, Rockville, Maryland, and Sun Ha Jee, MD, Graduate School of Public Health, Yonsei University, Seoul, South Korea, and colleagues assessed the association between chronic HBV infection and subsequent development of NHL in a South Korean cohort. Using data from The Korean Cancer Prevention Study, the researchers showed that 53,045 (9%) of 603 585 participants tested positive for HBV at baseline. Subsequently, 133 hepatitis-B positive (HBV+) and 905 hepatitis-B negative (HBV-) individuals developed NHL. HBV-positive participants had an increased risk of NHL overall compared with those who were HBV-negative (incidence 19.4 vs 12.3 per 100 000 person-years; translating to almost double the risk of NHL for HBV-positive individuals). NHL risk was increased consistently throughout 14 years of follow-up. Increased risk was also recorded for malignant immunoproliferation. Patients with HBV were almost 4 times as likely to develop this rare condition. Being HBV-positive was not associated with follicular or T-cell NHL, Hodgkin's lymphoma, multiple myeloma or various leukaemias. "In this large cohort study of healthy workers and their families in South Korea, we documented an excess risk of NHL in people infected with HBV…Additional research is needed to clarify whether the association between HBV infection and NHL is causal," the authors wrote. "For HCV-infected patients with low-grade NHL (especially marginal zone lymphomas), HCV treatment seems effective for haematological remission," the authors concluded. "Thus, we speculate that treatment directed at HBV in similar low-grade NHLs might lead to a clinical response and remove the need for chemotherapy. Further investigation in appropriate clinical series will be important." SOURCE: The Lancet Oncology E-mail this page to a friend or colleague! To print, use this version